ישראל - עברית - Ministry of Health

rekah pharmaceutical industry - isoniazid 50 mg - tablets - isoniazid - antibacterial, tubercolistic.

ישראל - עברית - Ministry of Health

teva pharmaceutical indust.ltd - metronidazole 250 mg - tablets - metronidazole - for the treatment of : - symptomatic trichomoniasis in women and men when the presence of the trichomonad has been confirmed by appropriate laboratory procedures. - asymptomatic trichomoniasis in women when the organism is associated with endocervicitis cervicitis or cervical erosion. - asymptomatic consort. - acute intestinal amebiasis (amebic dysentery) and amebic liver absess. - anaerobic bacterial infections caused by susceptible anaerobic bacteria.

ישראל - עברית - Ministry of Health

comex ltd - amoxicillin trihydrate 200 mg; clavulanic acid as potassium 50 mg - tablets - amoxicillin and enzyme inhibitor - for dogs : treatment of the following infections caused by beta lactamase producing strains of bacteria sensitive to amoxicillin in combination with clavulanic acid : skin infections ( including superficial and deep pyodermas ) caused by susceptible staphylococci. urinary tract infections caused by susceptible staphylococci or escherichia coli. respiratory infections caused by susceptible staphylococci. enteritis caused by susceptible escherichia coli.

ישראל - עברית - Ministry of Health

sanofi - aventis israel ltd - ofloxacin 200 mg - film coated tablets - ofloxacin - for the treatment of bacterial infections if these are due to ofloxacin sensitive pathogens.

ישראל - עברית - Ministry of Health

sanofi - aventis israel ltd - metronidazole 250 mg - film coated tablets - metronidazole - trichomonias, acute intestinal amebiasis. infections due to anaerobic bacteria.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - diphtheria toxoid; filamentous haemagglutinin (fha); inactivated polio virus (ipv) type 1; inactivated polio virus (ipv) type 2; inactivated polio virus (ipv) type 3; pertactin (prn or 69 kda omp); pertussis toxoid vaccine; tetanus toxoid - תרחיף להזרקה - pertactin (prn or 69 kda omp) 2.5 mcg / 0.5 ml; diphtheria toxoid nlt 2 iu / 0.5 ml; tetanus toxoid nlt 20 iu / 0.5 ml; filamentous haemagglutinin (fha) 8 mcg / 0.5 ml; pertussis toxoid vaccine 8 mcg / 0.5 ml; inactivated polio virus (ipv) type 3 32 du / 0.5 ml; inactivated polio virus (ipv) type 1 40 du / 0.5 ml; inactivated polio virus (ipv) type 2 8 du / 0.5 ml - bacterial and viral vaccines, combined - for booster vaccination against diphtheria, tetanus and pertusis and poliomyelitis of individuals from the age of four years onwards. boostrix polio is not intended for primary immunisation. the administration of boostrix polio should be based on official recommendations.

ישראל - עברית - Ministry of Health

sanofi israel ltd - metronidazole - טבליות מצופות פילם - metronidazole 250 mg - metronidazole - metronidazole - trichomonias, acute intestinal amebiasis. infections due to anaerobic bacteria.

ישראל - עברית - Ministry of Health

teva israel ltd - amoxicillin trihydrate - קפסולות - amoxicillin trihydrate 500 mg - amoxicillin - amoxicillin - infections caused by amoxycillin - susceptible organisms. prevention of bacteremia in patients at risk of developing bacterial endocarditis.

ישראל - עברית - Ministry of Health

abic marketing ltd, israel - amoxicillin as trihydrate - אבקה להכנת תרחיף - amoxicillin as trihydrate 250 mg / 5 ml - amoxicillin - amoxicillin - infections caused by amoxicillin - susceptible organisms and prevention of bacteremia in patients at risk of developing bacterial endocarditis.

ישראל - עברית - Ministry of Health

taro international ltd, israel - esomeprazole - טבליה - esomeprazole 20 mg - esomeprazole - esomeprazole - nexium tablets are indicated for: gastroesophageal reflux disease (gerd): - treatment of erosive reflux esophagitis - long-term management of patients with healed esophagitis to prevent relapse - symptomatic treatment of gastroesophageal reflux disease (gerd). in combination with an appropriate antibacterial therapeutic regimen for the eradication of helicobacter pylori and: - healing of helicobacter pylori associated duodenal ulcer and - prevention of relapse of peptic ulcers in patients with helicobacter pylory associated ulcers. - healing of gastric ulcers associated with nsaid therapy. - prevention of gastric and duodenal ulcers associated with nsaid therapy in patients at risk.prolonged treatment after i.v induced prevention of rebleeding of peptic ulcers.